Authors' Reply

Affiliations

¹ The Wilf Family Cardiovascular Research Institute, Department of Medicine (Cardiology), Albert Einstein College of Medicine, Bronx, New York.
² The Wilf Family Cardiovascular Research Institute, Department of Medicine (Cardiology), Albert Einstein College of Medicine, Bronx, New York. Electronic address: nikolaos.frangogiannis@einstein.yu.edu.

Olga Frunza et al. Am J Pathol. 2016 Aug.

. 2016 Aug;186(8):2234-2235.

doi: 10.1016/j.ajpath.2016.06.001. Epub 2016 Jul 20.

¹ The Wilf Family Cardiovascular Research Institute, Department of Medicine (Cardiology), Albert Einstein College of Medicine, Bronx, New York.
² The Wilf Family Cardiovascular Research Institute, Department of Medicine (Cardiology), Albert Einstein College of Medicine, Bronx, New York. Electronic address: nikolaos.frangogiannis@einstein.yu.edu.

Abstract

This correspondence is a reply to Galectin-3, Cardiac Function, and Fibrosis by Wouter C. Meijers et al.

1. Frunza O., Russo I., Saxena A., Shinde A.V., Humeres C., Hanif W., Rai V., Su Y., Frangogiannis N.G. Myocardial galectin-3 expression is associated with remodeling of the pressure-overloaded heart and may delay the hypertrophic response without affecting survival, dysfunction, and cardiac fibrosis. Am J Pathol. 2016;186:1114–1127. - PMC - PubMed
1. Filipe M.D., Meijers W.C., Rogier van der Velde A., de Boer R.A. Galectin-3 and heart failure: prognosis, prediction & clinical utility. Clin Chim Acta. 2015;443:48–56. - PubMed
1. Yu L., Ruifrok W.P., Meissner M., Bos E.M., van Goor H., Sanjabi B., van der Harst P., Pitt B., Goldstein I.J., Koerts J.A., van Veldhuisen D.J., Bank R.A., van Gilst W.H., Sillje H.H., de Boer R.A. Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis. Circ Heart Fail. 2013;6:107–117. - PubMed
1. Martinez-Martinez E., Calvier L., Fernandez-Celis A., Rousseau E., Jurado-Lopez R., Rossoni L.V., Jaisser F., Zannad F., Rossignol P., Cachofeiro V., Lopez-Andres N. Galectin-3 blockade inhibits cardiac inflammation and fibrosis in experimental hyperaldosteronism and hypertension. Hypertension. 2015;66:767–775. - PubMed
1. Calvier L., Martinez-Martinez E., Miana M., Cachofeiro V., Rousseau E., Sadaba J.R., Zannad F., Rossignol P., Lopez-Andres N. The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries. JACC Heart Fail. 2015;3:59–67. - PubMed